R X +
Live / Registered — Registered (as of 18 Oct 2022)
What this means for you
Registered since 18 Oct 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Oct 2028: the §8 declaration of use).
Record
- Serial number
- 88975404
- Registration number
- 6874844
- Mark type
- Design + words
- Filed
- 25 Jun 2018
- Published for opposition
- 14 Jul 2020
- Registered
- 18 Oct 2022
- Next maintenance filing
- §8 declaration of use, due by 18 Oct 2028 (grace period to 18 Apr 2029)
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct
Owner
- Astellas Pharma Inc., Chuo-ku, Tokyo, JP
- Astellas Pharma Inc., Chuo-ku, Tokyo, JP
- Astellas Pharma Inc., Chuo-ku, Tokyo, JP
Prosecution history
- 10 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Apr 2025 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 10 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Jul 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Jul 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 09 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 15 Sept 2022 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 31 Aug 2022 — NOTICE OF ALLOWANCE CANCELLED
- 31 Aug 2022 — TEAS DELETE 1(B) BASIS RECEIVED
- 03 Jun 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED